Cipla Limited announced the grant of stock options and employee stock appreciation rights (ESARs) to its employees. The grants are made under the “ESOS 2013-A” and “ESAR 2021” schemes. A total of 8,679 stock options and 27,140 ESARs have been granted. The stock options have a vesting period of 2 years from the grant date and an exercise period of 5 years from vesting. The ESARs feature a 3-year graded vesting and a 5-year exercise period from vesting.
Employee Stock Grant Details
Cipla Limited has officially communicated the grant of stock options and employee stock appreciation rights (ESARs) to its workforce. These grants are structured under two key employee benefit schemes: the Employee Stock Option Scheme 2013-A (ESOS 2013-A) and the Cipla Employee Stock Appreciation Rights Scheme 2021 (ESAR 2021). The disclosure follows a board meeting held on October 27, 2026.
Grant Allocation and Terms
Under the ESOS 2013-A scheme, a total of 8,679 stock options have been granted. These options are subject to a vesting period of 2 years from the grant date and can be exercised for a period of 5 years from the vesting date. The exercise price for these options is set at INR 2 per stock option.
Concurrently, the company has granted 27,140 Employee Stock Appreciation Rights (ESARs) under the ESAR 2021 scheme. These ESARs will vest on a 3-year graded basis. Similar to the stock options, the exercise period for these ESARs is 5 years from the vesting date, with an exercise price of INR 2 per equity share.
Source: BSE
